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Abstract
Introduction: To investigate if decreased exercise capacity is an indepen-
dent risk factor for major adverse cardiovascular events (MACE) in diabetics 
and nondiabetics.
Material and methods: The association of decreased exercise capacity (EC) 
during a treadmill exercise sestamibi stress test with MACE was investigated 
in 490 nondiabetics and 404 diabetics. Mean follow-up was 53 months.
Results: Nondiabetics with a predicted EC < 85% had a higher prevalence of 
myocardial ischemia (34% vs. 19%, p = 0.0002), 2- or 3-vessel obstructive cor-
onary artery disease (CAD) (31% vs. 13%, p = 0.016), myocardial infarction (MI) 
(17% vs. 7%, p = 0.0005), stroke (8% vs. 2%, p = 0.002), death (11% vs. 3%,   
p = 0.0002), and MI or stroke or death at follow-up (32% vs. 11%, p < 0.001) 
compared to nondiabetics with a predicted EC ≥ 85%. Diabetics with a predict-
ed EC < 85% had a higher prevalence of myocardial ischemia (48% vs. 32%,   
p = 0.0009), 2- or 3-vessel obstructive CAD (54% vs. 28%, p = 0.001), MI 
(32% vs. 14%, p < 0.001), stroke (22% vs. 6%, p < 0.001), death (17% vs. 9%,   
p = 0.031) , and MI or stroke or death at follow-up (65% vs. 27%, p < 0.001). 
Stepwise Cox regression analysis showed decreased EC was an independent 
and significant risk factor for MACE among nondiabetics (hazard ratio 3.3,   
p < 0.0001) and diabetics (hazard ratio 2.7, p < 0.0001).
Conclusions:  Diabetics and nondiabetics with decreased EC were at in-
creased risk for MACE with nondiabetics and decreased EC at similar risk as 
diabetics with normal EC.
Key words: exercise capacity, major adverse cardiac events, diabetes.
Introduction
A decreased exercise capacity (EC) has been associated with an in-
creased risk of all-cause mortality and major adverse cardiovascular 
events (MACE) [1–6]. The mechanism by which reduced EC increases 
mortality and MACE is unknown, but may be linked to increased inflam-
mation and concomitant endothelial dysfunction leading to accelerated B. Pierre-Louis, A.K. Guddati, M.K.H. Syed, V.E. Gorospe, M. Manguerra, C. Bagchi, W.S. Aronow, C. Ahn
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atherosclerotic disease [7–9]. Patients with de-
creased EC as demonstrated on a treadmill stress 
test have been shown to have a higher incidence 
of MACE, including myocardial infarction, stroke, 
and death, compared to those with normal EC 
[10]. These findings have been consistent among 
patients of different ethnicities, men and women, 
nondiabetics and diabetics, and patients with left 
ventricular hypertrophy [10, 11]. Multivessel coro-
nary artery disease (CAD) is also associated with 
increased cardiovascular events [12].
We performed a  study in 490 nondiabetics 
and 404 diabetics with no history of CAD to fur-
ther investigate the association of decreased EC 
during an exercise treadmill sestamibi stress test 
(TESST) with the prevalence of myocardial isch-
emia; the prevalence of 2- or 3-vessel obstructive 
CAD, and the incidence of myocardial infarction, 
stroke, death, and myocardial infarction or stroke 
or death. Coronary artery disease was diagnosed 
as previously described [13–21].
Material and methods
A TESST was performed as previously described 
[22] in 490 nondiabetics and 404 type 2 diabetics 
who were consecutive unselected patients with 
no history of CAD, peripheral vascular disease, di-
abetic neuropathy, chronic obstructive pulmonary 
disease, or other pulmonary disease that could 
possibly limit EC. These patients were referred for 
a TESST by a primary care physician or cardiolo-
gist because of chest pain or dyspnea (anginal 
symptoms) from 2005 to 2009. Diabetic patients 
were evaluated separately because diabetes is 
a recognized CAD equivalent and, therefore, these 
patients have a higher morbidity and mortality at 
baseline [23]. The patients were predominantly 
African-American and Latino from an urban pop-
ulation. 
All TESSTs were symptom-limited. Peak EC was 
measured as the percentage of maximal age- and 
sex-predicted metabolic equivalents (METs). The 
maximal predicted EC (100% predicted-METS) for 
each patient was calculated using previously vali-
dated models of functional capacity for women [2] 
and for men [24]. Achieved METs were determined 
from the final speed and grade of the treadmill. 
The percentage of maximal predicted EC achieved 
by each patient was calculated by dividing the 
METs achieved during exercise stress testing by 
the 100% predicted METs based on age and gen-
der. An achieved EC < 85% of predicted age- and 
gender-adjusted EC is associated with increased 
mortality [1–3] and was considered to be de-
creased. Nondiabetic patients with a decreased EC   
were compared regarding the prevalence of myo-
cardial ischemia and 2- or 3-vessel obstructive 
CAD and the incidence of myocardial infarction, 
stroke, or death during follow-up to nondiabetic 
patients with normal EC (≥ 85% predicted METS). 
The same comparisons were analyzed for diabetic 
patients. 
Two board-certified nuclear cardiologists re-
viewed the TESSTs for myocardial ischemia. Of the   
490 non-diabetic patients, 121 (25%) and 158 of   
the 404 diabetic patients (39%) underwent coro-
nary angiography because the TESST showed 
evidence of myocardial ischemia. The coronary 
angiograms were interpreted by 2 board-certified 
interventional cardiologists for the presence of 
obstructive CAD. Obstructive CAD was diagnosed 
if there was > 50% narrowing of at least 1 major 
coronary artery. The patients were followed for 
the incidence of myocardial infarction or stroke or 
death. Mean follow-up was 53 months.
Statistical analysis
Student’s t tests were performed to compare 
continuous variables between nondiabetic pa-
tients with decreased and normal EC and similarly 
for the diabetic patients. The c2 tests and Fisher’s 
exact tests were used to compare dichotomous 
variables between the respective groups. Stepwise 
Cox regression analysis was performed to identi-
fy significant independent prognostic risk factors 
for the time to myocardial infarction or stroke or 
death using the variables enumerated in the base-
line characteristic tables. The Institutional Review 
Board of Columbia University Medical Center ap-
proved this study.
Results
All patients stopped exercise because of dys-
pnea. No studies were terminated because of de-
conditioning, arrhythmias, intermittent claudica-
tion, or symptoms other than dyspnea.
Of 490 nondiabetic patients, 297 (61%) had 
a predicted EC ≥ 85% and 193 (39%) had a pre-
dicted EC < 85%. Table I shows the baseline char-
acteristics of nondiabetic patients with normal EC 
compared to those with decreased EC. No signifi-
cant differences were found between the 2 groups. 
Table II shows the prevalence of myocardial isch-
emia, obstructive CAD, multivessel CAD, and the 
incidence of myocardial infarction, stroke, death, 
and myocardial infarction or stroke or death in 
nondiabetic patients with normal EC compared to 
those with decreased EC. Table II also lists levels 
of statistical significance. Table III shows the step-
wise Cox regression analysis for the time to the 
development of myocardial infarction or stroke or 
death. A predicted EC < 85% was a significant in-
dependent predictor for the time to the develop-
ment of myocardial infarction or stroke or death. 
Nondiabetic patients with decreased EC had a ha-Exercise capacity as an independent risk factor for adverse cardiovascular outcomes among nondiabetic and diabetic patients
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Table II. Prevalence of myocardial ischemia, obstructive coronary artery disease, and multivessel coronary artery 
disease, and incidence of myocardial infarction, stroke, death and myocardial infarction or stroke or death in non-
diabetics with exercise capacity ≥ 85% vs. nondiabetics with exercise capacity < 85%
Clinical characteristics Nondiabetics 
 EC ≥ 85% (n = 297)
Nondiabetics 
 EC < 85% (n = 193)
Value of p
Myocardial ischemia 56 (19%) 65 (34%) 0.0002
Normal coronary arteries 29/56 (52%) 13/65 (20%) 0.0003
Non-obstructive CAD 12/56 (21%) 11/65 (17%) NS
1-vessel obstructive CAD 8/56 (14%) 21/65 (32%) 0.021
2-vessel obstructive CAD 4/56 (7%) 11/65 (17%) NS
3-vessel obstructive CAD 3/56 (5%) 9/65 (14%) NS
2- or 3-vessel obstructive CAD 7/56 (13%) 20/65 (31%) 0.016
Myocardial infarction  21 (7%) 33 (17%) 0.0005
Stroke 6 (2%) 15 (8%) 0.002
Death 9 (3%) 22 (11%) 0.0002
MI or stroke or death 33 (11%) 61 (32%) < 0.0001
CAD – coronary artery disease, MI – myocardial infarction, EC – exercise capacity, NS – not significant 
Table I. Baseline characteristics of nondiabetics with exercise capacity ≥ 85% vs. nondiabetics with exercise 
capacity < 85%
Clinical characteristics Nondiabetics 
EC > 85% (n = 297)
Nondiabetics 
 EC < 85% (n = 193)
Value of p
Age [years] 67.0 ±10.5 67.0 ±10.3 NS
Gender NS
Male 154 (52%) 102 (53%)
Female 143 (48%) 91 (47%)
Ethnicity NS
African-American 229 (77%) 156 (81%)
Latino 50 (17%) 29 (15%)
White 8 (3%) 4 (2%)
Asian 10 (3%) 4 (2%)
BMI > 30 kg/m2 92 (31%) 64 (33%) NS
Hypertension  240 (81%) 160 (83%) NS
Dyslipidemia  214 (72%) 147 (76%) NS
Smoking 40 (13%) 23 (12%) NS
GFR ≥ 60 ml/min/1.73 m2 220 (74%) 139 (72%) NS
GFR 30–59 ml/min/1.73 m2 65 (22%) 44 (23%) NS
GFR ≤ 30 ml/min/1.73 m2 12 (4%) 10 (5%) NS
Aspirin 270 (91%) 172 (89%) NS
Statins 205 (69%) 139 (72%) NS
b-Blockers 140 (47%) 83 (43%) NS
ACE inhibitors/ARBs 211 (71%) 143 (74%) NS
Follow-up [months] 55.7 ±19.0 53.6 ±18.6 NS
EC – exercise capacity, BMI – body mass index, GFR – glomerular filtration rate, ACE – angiotensin- converting enzyme, ARB – angioten-
sin receptor blocker, NS – not significantB. Pierre-Louis, A.K. Guddati, M.K.H. Syed, V.E. Gorospe, M. Manguerra, C. Bagchi, W.S. Aronow, C. Ahn
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zard ratio of 3.3 (p < 0.0001) for the incidence of 
myocardial infarction or stroke or death during 
the follow-up period. Hypertension, dyslipidemia 
and smoking were also independent risk factors 
for MACE as has been previously demonstrated in 
other studies [25–27].
Of the 404 diabetic patients, 223 (55%) had a pre  -
dicted EC ≥ 85% and 181 (45%) had a predicted 
EC < 85%. Table IV shows the baseline characteris-
tics of diabetic patients with normal EC compared 
to those with decreased EC. No significant differ-
ences were found between the 2 groups. Table 
V shows the prevalence of myocardial ischemia, 
obstructive CAD, multivessel CAD, and the inci-
dence of myocardial infarction, stroke, death, and 
myocardial infarction or stroke or death in diabetic 
patients with normal EC compared to those with 
decreased EC. Table V also lists levels of statisti-
cal significance. Table VI shows the stepwise Cox 
regression analysis for the time to the develop-
ment of myocardial infarction or stroke or death. 
A predicted EC < 85% was a significant indepen-
dent predictor for the time to the development of 
myocardial infarction or stroke or death. Diabetic 
Table III. Stepwise Cox regression analysis for the time to the development of myocardial infarction, stroke, or 
death among nondiabetics with exercise capacity ≥ 85% vs. nondiabetics with exercise capacity < 85%
Outcome Variable Parameter estimate 
(± STD)
Hazard ratio   
(95% CI)
Value of p
MI, stroke, or 
death
Exercise capacity < 85% of predicted 
metabolic equivalents achieved
1.20 ±0.22 3.3 (2.2–5.1) < 0.0001
MI – myocardial infarction 
Table IV. Baseline characteristics of diabetics with exercise capacity ≥ 85% vs. diabetics with exercise capacity < 85%
Clinical characteristics Diabetics 
 EC ≥ 85% (n = 223)
Diabetics 
EC < 85% (n = 181)
Value of p
Age [years] 67.7 ±10.4 67.0 ±10.4 NS
Gender NS
Male 109 (49%) 88 (49%)
Female 114 (51%) 93 (51%)
Ethnicity NS
African-American 165 (74%) 139 (77%)
Latino 44 (20%) 33 (18%)
White 6 (3%) 4 (2%)
Asian 8 (4%) 5 (3%)
BMI > 30 kg/m2 76 (34%) 65 (36%) NS
Hypertension  212 (95%) 170 (94%) NS
Dyslipidemia  214 (96%) 176 (97%) NS
Smoking 40 (18%) 32 (18%) NS
GFR ≥ 60 ml/min/1.73 m2 125 (56%) 99 (55%) NS
GFR 30–59 ml/min/1.73 m2 74 (33%) 63 (35%) NS
GFR ≤ 30 ml/min/1.73 m2 24 (11%) 19 (10%) NS
Aspirin 212 (95%) 174 (96%) NS
Statins 207 (93%) 172 (95%) NS
b-Blockers 198 (89%) 165 (91%) NS
ACE inhibitors/ARBs 214 (96%) 176 (97%) NS
Insulin 87 (39%) 74 (41%) NS
Follow-up [months] 50.4 ±18.6 50.9 ±16.2 NS
EC – exercise capacity, BMI – body mass index, GFR – glomerular filtration rate, ACE – angiotensin- converting enzyme, ARB – angioten-
sin receptor blocker, NS – not significantExercise capacity as an independent risk factor for adverse cardiovascular outcomes among nondiabetic and diabetic patients
Arch Med Sci 1, February / 2014 29
patients with decreased EC had a hazard ratio of 
2.7 (p < 0.0001) for the incidence of myocardial 
infarction or stroke or death during the follow-up 
period. Hypertension, dyslipidemia and smoking 
were also independent risk factors for MACE as 
has been previously demonstrated in other studies 
[25–27] and should be managed [28, 29].
Table VII shows the baseline characteristics 
of diabetic patients with normal EC compared to 
nondiabetic patients with decreased EC. and lev-
els of statistical significance. Table VIII shows the   
prevalence of myocardial ischemia, obstructive CAD, 
multivessel CAD, and the incidence of myocardial 
infarction, stroke, death, and myocardial infarc-
tion or stroke or death in diabetic patients with 
normal EC compared to nondiabetic patients with 
decreased EC. Table VIII also lists levels of statisti-
cal significance.
Discussion
The present study provides further evidence 
that decreased EC as determined by METS during 
a TESST is a significant risk factor for MACE. In 
particular, this study confirms these findings in 
a  population of primarily African-American and 
Latino patients in an urban community, which 
few studies have previously investigated. These 
findings correspond to data published in previous 
studies and further demonstrate that the findings 
are consistent across different patient popula-
tions. 
In a prior study of 609 diabetic patients who 
underwent symptom limited TESSTs for chest pain 
or dyspnea, patients with a predicted EC > 85% 
had a 48% lower change of MI, stroke, or death 
at 47-month follow-up [10]. A  study conducted 
at the Veterans Affairs Medical Center in Wash-
ington, DC involving 866 diabetic men with and 
without left ventricular hypertrophy who under-
went an exercise stress test showed that normal 
EC was associated with a 43% lower mortality risk 
among patients with left ventricular hypertrophy 
and a 41% lower mortality risk among those with-
out left ventricular hypertrophy [11].  In a study 
involving 6.2-year follow-up of 6213 men referred 
for treadmill exercise testing, researchers demon-
strated that each 1-MET increase in EC conferred 
a 12% improvement in survival [1]. The St. James 
Women Take Heart Project revealed that at 8-year 
follow-up of 5721 asymptomatic women under-
Table V. Prevalence of myocardial ischemia, obstructive coronary artery disease, and multivessel coronary artery 
disease, and incidence of myocardial Infarction, stroke, death and myocardial infarction or stroke or death in dia-
betics with exercise capacity ≥ 85% vs. diabetics with exercise capacity < 85%
Clinical characteristics Diabetics 
 EC ≥ 85% (n = 223)
Diabetics 
 EC < 85% (n = 181)
Value of p
Myocardial ischemia 71 (32%) 87 (48%) 0.0009
Normal coronary arteries 20/71 (28%) 6/87 (7%) 0.0003
Non-obstructive CAD 13/71 (18%) 8/87 (9%) NS
1-vessel obstructive CAD 18/71 (25%) 26/87 (30%) NS
2-vessel obstructive CAD 11/71 (15%) 24/87 (28%) NS
3-vessel obstructive CAD 9/71 (13%) 23/87 (26%) 0.032
2- or 3-vessel obstructive CAD 20/71 (28%) 47/87 (54%) 0.001
Myocardial infarction 32 (14%) 58 (32%) < 0.0001
Stroke 14 (6%) 39 (22%) < 0.0001
Death 21 (9%) 30 (17%) 0.031
MI or stroke or death 60 (27%) 117 (65%) < 0.0001
CAD – coronary artery disease, MI – myocardial infarction, EC – exercise capacity, NS – not significant
Table VI. Stepwise Cox regression analysis for the time to the development of myocardial infarction, stroke, or 
death among diabetics with exercise capacity ≥ 85% vs. diabetics with exercise capacity < 85%
Outcome Variable Parameter estimate 
± STD
Hazard ratio  
(95% CI)
Value of p
MI, stroke, 
death
Exercise capacity < 85% of predicted 
metabolic equivalents achieved
0.98 ±0.16 2.7 (1.9–3.7) < 0.0001
MI – myocardial infarction B. Pierre-Louis, A.K. Guddati, M.K.H. Syed, V.E. Gorospe, M. Manguerra, C. Bagchi, W.S. Aronow, C. Ahn
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Table VII. Baseline characteristics of diabetics with exercise capacity ≥ 85% vs. nondiabetics with exercise capacity 
< 85% 
Clinical characteristics Diabetics 
 EC ≥ 85% (n = 223)
Nondiabetics 
 EC < 85% (n = 193)
Value of p
Age [years] 67.7 ±10.4 67 ±10.3 NS
Gender NS
Male 109 (49%) 102 (53%)
Female 114 (51%) 91 (47%)
Ethnicity NS
African-American 165 (74%) 156 (81%)
Latino 44 (20%) 29 (15%)
White 6 (3%) 4 (2%)
Asian 8 (4%) 4 (2%)
BMI > 30 kg/m2 76 (34%) 64 (33%) NS
Hypertension  212 (95%) 160 (83%) 0.0001
Dyslipidemia  214 (96%) 147 (76%) < 0.0001
Smoking 40 (18%) 23 (12%) NS
GFR ≥ 60 ml/min/1.73 m2 125 (56%) 139 (72%) 0.0007
GFR 30–59 ml/min/1.73 m2 74 (33%) 44 (23%) 0.019
GFR ≤ 30 ml/min/1.73 m2 24 (11%) 10 (5%) 0.038
Aspirin 212 (95%) 172 (89%) 0.023
Statins 207 (93%) 139 (72%) < 0.0001
b-Blockers 198 (89%) 83 (43%) < 0.0001
ACE inhibitors/ARBs 214 (96%) 143 (74%) < 0.0001
Insulin 87 (39%) 0 < 0.0001
Follow-up [months] 50.4 ±18.6 53.5 ±18.6 NS
EC – exercise capacity, BMI – body mass index, GFR – glomerular filtration rate, ACE – angiotensin-converting enzyme, ARB – angiotensin 
receptor blocker, NS – not significant
going treadmill exercise testing, Framingham risk 
score-adjusted hazards ratios of death associated 
with MET levels of < 5, 5 to 8, and > 8 were 3.1, 
1.9, and 1.0, respectively [2]. 
In addition, at 8.4-year follow-up of 5721 asymp-
tomatic women who had a treadmill exercise test, 
women with a predicted EC < 85% had a hazard 
ratio for death of 2.0 and for cardiac death of 2.4 
compared with women with a predicted EC ≥ 85% 
[2]. In another study involving 2.7-year follow-up 
of 9191 patients referred for treadmill exercise 
testing, a predicted EC < 85% was associated with 
an increased risk of myocardial infarction (hazard 
ratio: 2.4), unstable angina (hazard ratio: 2.4), cor-
onary revascularization (hazard ratio: 1.8), and 
death (hazard ratio: 2.9) compared with a predict-
ed EC > 100% [3].
At 7.5-year follow-up of 8911 white men and 
6749 black men who underwent a treadmill exer-
cise test, researchers demonstrated that EC was 
the strongest predictor of mortality and the ad-
justed risk of mortality was reduced by 13% for 
each 1-MET increase in EC [4]. A meta-analysis of 
33 studies involving 102,980 persons for mortality 
and 84,323 persons for CAD/cardiovascular dis-
ease events showed that the relative risk of mor-
tality and of CAD/cardiovascular disease events 
per 1-MET higher level of maximal aerobic capaci-
ty were 0.87 and 0.85, respectively [5]. 
In a study focused on the primary prevention 
benefits of exercise, researchers found that of 
104 patients with abnormal treadmill exercise 
test results with ischemic ST-segment depression 
achieved after exercising for ≥ 10 METs, death oc-
curred at 7.2-year follow-up in 1 of 104 patients 
(1%) [30]. The investigators concluded that pa-
tients with ischemic ST-segment depression on 
a treadmill exercise test who achieved workloads Exercise capacity as an independent risk factor for adverse cardiovascular outcomes among nondiabetic and diabetic patients
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Table VIII. Prevalence of myocardial ischemia, obstructive coronary artery disease, multivessel coronary artery dis-
ease, and incidence of myocardial infarction, stroke, death and myocardial infarction or stroke or death in diabetics 
with exercise capacity ≥ 85% vs. nondiabetics with exercise capacity < 85%
Clinical characteristics Diabetics 
 EC ≥ 85% (n = 223)
Nondiabetics 
 EC < 85% (n = 193)
Value of p
Myocardial ischemia 71 (32%) 65 (34%) NS
Normal coronary arteries 20/71 (28%) 13/65 (20%) NS
Non-obstructive CAD 13/71 (18%) 11/65 (17%) NS
1-vessel obstructive CAD 18/71 (25%) 21/65 (32%) NS
2-vessel obstructive CAD 11/71 (15%) 11/65 (17%) NS
3-vessel obstructive CAD 9/71 (13%) 9/65 (14%) NS
2- or 3-vessel obstructive CAD 20/71 (28%) 20/65 (31%) NS
Myocardial infarction 32 (14%) 33 (17%) NS
Stroke 14 (6%) 15 (8%) NS
Death 21 (9%) 22 (11%) NS
MI or stroke or death 60 (27%) 61 (32%) NS
CAD – coronary artery disease, MI – myocardial infarction, EC – exercise capacity, NS – not significant
of ≥ 10 METs infrequently require additional non-
invasive or invasive evaluation [30]. 
The present study of 490 nondiabetic and 404   
diabetic patients with no history of CAD who 
had a TESST because of chest pain or dyspnea 
showed that persons with a predicted EC < 85% 
had a  higher incidence of myocardial ischemia 
and 2- or 3-vessel obstructive CAD. At 53-months 
follow-up, the incidence of myocardial infarction, 
stroke, or death was also significantly increased 
in those with a predicted EC < 85%. Stepwise Cox 
regression analysis showed that a predicted EC 
< 85% was a  significant independent predictor 
of the time to the development of myocardial in-
farction, stroke, or death among both nondiabet-
ic and diabetic patients. In addition, a univariate 
comparison of MACE between diabetic patients 
with normal EC, and nondiabetic patients with de-
creased EC revealed no significant differences in 
the prevalence of myocardial ischemia and 2- or 
3-vessel obstructive CAD or the incidence of myo-
cardial infarction, stroke, or death at 53-months 
follow-up. These clinical findings contribute new 
information to the medical literature. This suggest 
that decreased EC may be a coronary artery dis-
ease equivalent. This finding requires further in-
vestigation in a prospective study. 
The mechanism for increased mortality and 
cardiovascular events in patients with a reduced 
EC is unknown. Regular aerobic exercise has been 
shown to decrease vascular inflammation and 
improve endothelial function. Therefore, patients 
with decreased EC may have an accelerated ath-
erosclerotic process [7]. This is supported by the 
increased prevalence of myocardial ischemia 
and multivessel obstructive CAD among patients 
with decreased EC in the study which may have 
caused their increased mortality and morbidity. 
The independent association of decreased EC and 
increased incidence of MACE among both nondia-
betic and diabetic patients suggest that this may 
be a significant modifiable risk factor that should 
be evaluated among all patients at risk for heart 
disease. The patients in the current study were 
at increased baseline risk because of the preva-
lence of cardiovascular risk factors, ethnicity, so-
cioeconomic status, and the presence of anginal 
symptoms prompting referral for a  stress test. 
This study and the existing body of data indicate 
that EC as determined by METS during a treadmill 
stress test should potentially be screened among 
patients with risk factors for MACE. Those with de-
creased EC would then be considered at increased 
risk for MACE and should have specific interven-
tions implemented to reduce that risk including 
ideally supervised exercise training and follow-up 
EC testing.
The patient population studied is from a sin-
gle center with a high-risk cohort involving a pri-
marily African-American and Latino population. 
Therefore, generalizing our findings to other pop-
ulations has limitations. A long-term, prospective 
study of consecutive patients to investigate the 
significance of decreased EC as a modifiable car-
diovascular risk factor among patients with exist-
ing risk factors for MACE (diabetes, hypertension, 
dyslipidemia and smoking), but no active anginal 
symptoms is currently underway at our institu-
tion. Whether increasing physical activity in pa-
tients with a decreased EC will reduce mortality B. Pierre-Louis, A.K. Guddati, M.K.H. Syed, V.E. Gorospe, M. Manguerra, C. Bagchi, W.S. Aronow, C. Ahn
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and cardiovascular events will be investigated by 
this prospective trial.
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